PDCD1 and obesity due to melanocortin 4 receptor deficiency: In melanoma, non-small cell lung cancer, and renal cell cancer, patients with overweight/obesity showed high efficacy of anti-PD-1/PD-L1 treatment compared to normal-weight patients [134].